Literature DB >> 34216273

Echocardiography in the Liver Transplant Patient.

Parul Kakar1, James Gubitosa2, Christine Gerula2.   

Abstract

PURPOSE OF REVIEW: The aim of this study is to review current echocardiographic modalities utilized in the assessment of the preoperative liver transplant candidate with an emphasis on newer techniques. We sought to assess if newer methods imparted additional diagnostic or prognostic accuracy compared to prior methods based on existing studies. RECENT
FINDINGS: Standard dobutamine stress echocardiography offers important information regarding operative risk and post-operative survival in liver transplant candidates; however, technologies such as speckle-tracking echocardiography (STE) and evaluation of diastolic function have emerged as useful tools as well. 2D-STE and diastolic echocardiography offer additional parameters such as global longitudinal strain and measures of diastolic dysfunction that can better predict peri-operative and post-operative complications in liver transplant candidates. If able, practitioners should utilize these methods routinely in their assessment of liver transplant candidates.

Entities:  

Keywords:  Cirrhosis; Cirrhotic cardiomyopathy; Echocardiography; Liver transplant; Speckle-tracking; Strain

Mesh:

Year:  2021        PMID: 34216273     DOI: 10.1007/s11886-021-01531-1

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  30 in total

1.  Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis.

Authors:  R P Woitas; J Heller; B Stoffel-Wagner; U Spengler; T Sauerbruch
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

2.  Anatomical cardiac alterations in liver cirrhosis: an autopsy study.

Authors:  Nayeli X Ortiz-Olvera; Guillermo Castellanos-Pallares; Luz M Gómez-Jiménez; María L Cabrera-Muñoz; Jorge Méndez-Navarro; Segundo Morán-Villota; Margarita Dehesa-Violante
Journal:  Ann Hepatol       Date:  2011 Jul-Sep       Impact factor: 2.400

3.  Cardiac muscarinic receptor function in rats with cirrhotic cardiomyopathy.

Authors:  D N Jaue; Z Ma; S S Lee
Journal:  Hepatology       Date:  1997-06       Impact factor: 17.425

4.  Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

Authors:  Paul Martin; Andrea DiMartini; Sandy Feng; Robert Brown; Michael Fallon
Journal:  Hepatology       Date:  2014-03       Impact factor: 17.425

Review 5.  Cirrhotic cardiomyopathy.

Authors:  Enrico M Zardi; Antonio Abbate; Domenico Maria Zardi; Aldo Dobrina; Domenico Margiotta; Benjamin W Van Tassell; Benjamin W Van Tassel; Antonella Afeltra; Arun J Sanyal
Journal:  J Am Coll Cardiol       Date:  2010-08-10       Impact factor: 24.094

6.  Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity.

Authors:  M Levy; M J Wexler
Journal:  J Lab Clin Med       Date:  1978-03

Review 7.  Cirrhotic cardiomyopathy.

Authors:  Søren Møller; Jens H Henriksen
Journal:  J Hepatol       Date:  2010-03-31       Impact factor: 25.083

8.  Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy.

Authors:  C A Ward; H Liu; S S Lee
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

Review 9.  New therapeutic approaches to liver fibrosis: a practicable route?

Authors:  Enrico M Zardi; Aldo Dobrina; Giovanni Ambrosino; Domenico Margiotta; Francesco Polistina; Antonella Afeltra
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

10.  Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics.

Authors:  M Bernardi; L Fornalè; C Di Marco; F Trevisani; M Baraldini; A Gasbarrini; C De Collibus; F Zacà; A Ligabue; A Colantoni
Journal:  J Hepatol       Date:  1995-03       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.